Connect with us

Technology

Health Canada Licenses Landmark Canadian Stethophone App

Published

on

Health Canada has licensed Stethophone®, a Canadian-developed, AI-powered app that allows users to capture and analyze heart sounds using only a smartphone. Designed for both healthcare professionals and personal use, Stethophone helps detect structural and rhythmic heart anomalies at the precise moment symptoms or concerns arise.

ST. JOHN’S, Newfoundland, Nov. 5, 2024 /PRNewswire-PRWeb/ — Health Canada has licensed Stethophone®, a Canadian-developed, AI-powered app that allows users to capture and analyze heart sounds using only a smartphone. Designed for both healthcare professionals and personal use, Stethophone helps detect structural and rhythmic heart anomalies at the precise moment symptoms or concerns arise.

“Stethophone has achieved a big leap in both medical accuracy and convenience over other professional-grade devices, at a fraction of the cost,” Dr. Yaroslav Shpak co-Founder and Chief Medical Office.

Stethophone is classified as a regulated medical device, meaning it must adhere to strict protocols for user protection, accurate performance, and secure data handling. Health Canada approval signifies that Stethophone meets these stringent standards delivering reliable, high-quality insights into heart health, giving both users and healthcare providers confidence in this groundbreaking technology.

“This authorization from Health Canada allows us to offer Stethophone to every Canadian with a heart concern, whether for themselves or someone in their care,” said Mark Opauszky, CEO of Sparrow BioAcoustics.

“Testing and validation involved thousands of patients, supported by doctors from Canada and the international cardiology community.” Said Nadia Ivanova founder and Chief Product Officer at Sparrow.

” Stethophone has achieved a big leap in both medical accuracy and convenience over other professional-grade devices, at a fraction of the cost,” added Dr. Yaroslav Shpak co-Founder and Chief Medical Officer. “Helping to capture and identify symptoms at home goes a long way to ensuring people are treated before conditions progress too far.”

Stethophone is expected to launch within days, signalling Canada’s leadership in medical AI. This landmark approval highlights the potential for mobile technology to play a pivotal role in population-wide heart health, providing Canadians and the world with a new, trusted tool for heart sound analysis.

For more information about Stethophone and Sparrow BioAcoustics, visit https://stethophone.com/.

About Sparrow BioAcoustics

Sparrow BioAcoustics, with offices in Newfoundland and Nova Scotia, is leading the Software as a Medical Device industry in new directions for cardiac and pulmonary disease detection. Their team of physicians, engineers and data scientists are working to unlocking the richest sources of diagnostic information about cardiac and pulmonary conditions for the population. Their mission is to help the millions of people at-risk and suffering from cardiac and respiratory disease to live longer, healthier lives enabled by earlier detection and quicker treatment.

Media Contact
Mark Opauszky, Mark Opauszky, 1 4162688966, mark@sparrowacoustics.com, sparrowbioacoutics.com

View original content to download multimedia:https://www.prweb.com/releases/health-canada-licenses-landmark-canadian-stethophone-app-302296172.html

SOURCE Sparrow BioAcoustics

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Duoning Biotech announced strategic partnership with Branca Bunús to promote the next generation of transfection reagents

Published

on

By

SHANGHAI, Nov. 5, 2024 /PRNewswire/ — Duoning Biotechnology Group (“Duoning”) announced a strategic partnership agreement with Branca Bunús Ltd. (“Branca Bunús”). Under this agreement, the two companies will collaborate on the development, optimization, and application of transfection reagents, with the goal of providing  biopharmaceutical customers with innovative transfection reagents through resource sharing, thereby enhancing the efficiency of biopharmaceutical development in upstream bioprocess.

Branca Bunús is a gene delivery technology company based in Ireland, specializing in the development of safe gene delivery vectors and effective transfection reagents derived from unique cationic polymer materials. Guided by a product development philosophy that emphasizes high efficiency, biocompatibility, and significant clinical and industrial application value, Branca Bunús has created the BrPERfect® series of transfection reagents. The company also offers supporting services, including the development of targeted gene delivery vectors and directional optimization. As a well-established one-stop bioprocess solution provider in China, Duoning Biotech’s offerings encompass the entire bioprocess workflow, from upstream cell culture to downstream filtration and purification. Additionally, Duoning Biotech provides services such as media production, process optimization, and validation testing.

After the cooperation is established, Branca Bunús will be responsible for the research, development, and performance enhancement of transfection reagents. This includes scientific research applications involving DNA, siRNA, and mRNA transfection, as well as the production of recombinant proteins, AAV, and LV based on the transient transfection of CHO and HEK 293 cells. Duoning will leverage its established sales network and collaborative sales strategy for upstream process products to comprehensively promote this solution. Additionally, both parties will form a specialized research and marketing team to optimize the transient transfection process by examining the interaction principles of transfection reagents and cell culture media. They will also conduct market research to develop a comprehensive solution for the application of transfection reagents.

Hongfeng Gu, Vice President of Duoning, stated, “Branca Bunús is an emerging biotechnology company that has developed a leading hyperbranched polymer gene delivery vector platform, founded by Professor Wenxin Wang. We are honored to collaborate with companies that possess core technologies. The BrPERfect® series of transfection reagents from Branca Bunús, combined with Duoning’s cell culture media, bioreactors, and other products, will offer customers more comprehensive upstream bioprocessing solutions.”

Dr. Zhonglei He, Chief Technology Officer of Branca Bunús, stated, “The significant contribution of Duoning to the rapid development of the biotechnology market is evident to all. We are honored to collaborate with Duoning, particularly in its one-stop bioprocessing solutions. Our goal is to provide efficient and stable transfection reagent products and process support, ensuring timely and high-quality products and services for various R&D and production applications, including transient protein production and screening in downstream processes, stem cell enhancement, and the production of diverse viral vectors through transient transfection.”

About Duoning

Shanghai Duoning Biotechnology Co., Ltd. (“Duoning”) is a leading one-stop bioprocess solutions provider in China, committed to offering products and services required for the discovery, development and commercialization production of biologics, including reagents, consumables, instruments, equipment, and validation services. Leveraging our integrated bioprocess system, we empower our partners to achieve effective, reliable, lower-cost and higher-quality biologics production processes. For more information, please visit: www.duoningbio.com/en

For media inquiries, please contact: PR@duoningbio.com 

About Branca Bunús

Branca Bunús is an emerging Irish biotechnology company specializing in innovative gene delivery technologies. Leveraging over a decade of research by its founding technical team, the company focuses on the development and production of advanced gene delivery vectors and transfection reagents. Branca Bunús aims to provide cost-effective, high-yield transient transfection solutions, along with supporting services such as targeted gene delivery vector development and directional optimization. The company is dedicated to transforming groundbreaking discoveries into life-changing practical applications. To learn more, please visit: http://brancabunus.com

View original content:https://www.prnewswire.com/news-releases/duoning-biotech-announced-strategic-partnership-with-branca-bunus-to-promote-the-next-generation-of-transfection-reagents-302297073.html

SOURCE Duoning

Continue Reading

Technology

UnionPay International joins forces with industry players to optimize payment experience for international visitors to China

Published

on

By

Global UnionPay Cards Now Support Weixin Pay and Alipay

SHANGHAI, Nov. 5, 2024 /CNW/ — UnionPay International (UPI) announced that Alipay and Weixin payments are fully enabled for UnionPay cards issued outside China’s mainland, providing more diversified, convenient and inclusive payment options for inbound travelers to China. The collaboration with Weixin Pay is supported through the Industrial and Commercial Bank of China (ICBC).

In order to further optimize payment services, UnionPay launched Project Excellence 2024 in March, joining hands with various industry stakeholders to build a convenient, inclusive, and accessible payment ecosystem. This collaboration is the latest achievement of the Project. From now on, international travelers to China can download Alipay or Wexin applications, link their local UnionPay cards, and enjoy the same convenience of QR payments as the Chinese users do.

This innovative payment method will provide more convenience for inbound visitors to pay in China: No service fee will apply throughout the payment process as initial promotion, which enables users to make payments as if they were at home. Online and offline use cases are covered, including F&B, accommodation, transit, sightseeing, shopping and entertainment. The new method supports consumer-presented, merchant-presented, in-app payment and ETC, which removes the payment barriers for users who are travelling, working or living in China. The new enablement is easy to use, as cardholders only need to enter the UnionPay card information required, and complete the linking process once the card issuer performs the authentication.

This collaboration manifests UPI’s stepped-up efforts to work with other industry stakeholders to promote payment interoperability and develop a sustainable business model. It will help to further bridge the differences in payment preference between China and the rest of the world, facilitate the country’s high-standard opening up.

UnionPay’s international business has become increasingly localized in the past few years, and more and more consumers outside China are enjoying the convenient services brought by UnionPay. Over 250 million UnionPay cards have been issued in 83 countries and regions outside China’s mainland, which can be used for payments in 183 countries and regions. UnionPay has also launched SplendorPlus, a new card product tailored to international visitors to China. The themed card, which comes with diverse benefits and special merchant offers in China, has proven to be highly popular.

 

View original content:https://www.prnewswire.com/news-releases/unionpay-international-joins-forces-with-industry-players-to-optimize-payment-experience-for-international-visitors-to-china-302296568.html

SOURCE UnionPay International

Continue Reading

Technology

Horizons Shines at CIIE 2024 with Global Leader Recognition in G2’s Fall 2024 Reports

Published

on

By

SHANGHAI, Nov. 5, 2024 /PRNewswire/ — Horizons, a leading global Employer of Record (EOR) provider, proudly launches its latest Global HR Strategy at the 2024 China International Import Expo (CIIE) from November 5 to 10 in Shanghai. Under the theme “Talent Without Borders, Vision Without Limits,” Horizons will showcase its commitment to empowering a borderless workforce and present its innovative SaaS HR platform, designed to enhance HR compliance, simplify payroll, and streamline employee and contractor payment for businesses worldwide..

At CIIE, Horizons will demonstrate how advancements in technology, including AI, big data, and cloud computing, are reshaping HR management. The event will also highlight Horizons’ strategic collaborations with other innovators in the sector to support both global and Chinese enterprises in expanding their workforces across borders.

Coinciding with its presence at CIIE, Horizons has been recognized as a Global Leader in G2‘s Fall 2024 Reports across multiple categories in Global Employment Platforms (GEP) and Contractor Management. This recognition underscores Horizons’ dedication to a full range of global hiring solutions, covering both contractors and employees.

Horizons Fall 2024 G2 Recognitions

Leader in Mid-Market EMEA Contractor ManagementLeader in EMEA Global Employment Platforms (GEP)Leader in Mid-Market Global Employment Platforms (GEP) – Recognized for Easiest Admin and Easiest To Do Business WithLeader in Global Employment Platforms (GEP) – Recognized for Easiest AdminLeader in Small-Business Global Employment Platforms (GEP)Users Love Us: Awarded for consistently high customer satisfaction ratings

“Horizons’ mission is to build solutions that empower the borderless workforce, and our vision is to create equal opportunity for all,” said Antoine Boquen, Horizons’ CEO and Co-founder. “Our G2 recognition across multiple categories, and presence at CIIE, reflect our continued dedication to businesses of all sizes in their global hiring journey.  We firmly believe that location should be no barrier to businesses hiring the best talent, and professionals finding the best workplace.

About Horizons

Horizons is a leading global Employer of Record (EOR), transforming how businesses hire internationally. Our innovative platform simplifies global hiring by managing compliance, payroll, and payments through established local infrastructure in over 100 countries. Trusted by over 3,000 businesses, Horizons enables companies of all sizes to hire overseas talent quickly and cost-effectively.

Learn more: https://joinhorizons.com/

Contacts

Lily Zhang, Digital Marketing Manager at Horizons

lily.zhang@horizons.com 

View original content:https://www.prnewswire.com/news-releases/horizons-shines-at-ciie-2024-with-global-leader-recognition-in-g2s-fall-2024-reports-302296380.html

SOURCE Horizons

Continue Reading

Trending